defunct biotechnology companies: mergers and acquisitions, business liquidation, insolvency, renaming

Defunct Biotechnology Companies

SQ-SZ

Strakan Group Ltd.	merged to	ProStrakan Group plc.	2004
Strata Biosciences, Inc.	acquired by	GeneTrace Systems, Inc.	2000
Stressgen Bioreagents Corp.	acquired by	Assay Designs, Inc.	2005
Structural Bioinformatics, Inc.	merged to	Cengent Therapeutics, Inc.	2003
Structural GenomiX, Inc.	renamed	SGX Pharmaceuticals, Inc.	2005
Sugen, Inc.	acquired by	Pharmacia Corp.	2001
SunPharm Corp.	acquired by	Geltex Pharmaceuticals	1999
SunVax, Inc.	renamed	Tolerion, Inc.	2002
SuperArray Biosciences Corp.	renamed	SA Biosciences Corp.	2008
Survac ApS	acquired by	Merck KGaA	2005
Sympore GmbH	insolvency		2004
Synergen, Inc.	acquired by	Amgen, Inc.	1994
Synthetic Blood International, Inc.	renamed	Oxygen Biotherapeutics, Inc.	2008
Systems Integration Drug Discovery Company, Inc. (SIDDCO)	acquired by	Discovery Partners International	2000
1 2 3 <previous